Praj and Gevo sign Bio-IBA commercialization deal for India

Praj Industries and Gevo, Inc. (NASDAQ: GEVO) announced the signing of a Development & Commercialization Agreement for Bio-Isobutanol (Bio-IBA) technology in India, according to a press release dated Sept. 16, 2026.

Under the agreement, Praj will hold exclusive rights to deploy Gevo's Bio-IBA technology in India, with a primary focus on diesel blending applications. The two companies have maintained a working relationship for more than a decade developing Bio-IBA technology for Indian feedstocks and market conditions.

Separately, Praj is establishing what it describes as India's first commercial Bio-IBA demonstration plant for a leading Oil Marketing Company. The plant is being designed, engineered, supplied and erected by Praj using Gevo's licensed Bio-IBA technology. The facility is intended to validate production, supply-chain and market-development pathways for future commercialization in India.

According to India's Petroleum Planning & Analysis Cell, India consumed approximately 94.7 million tonnes (29.7 billion U.S. gallons) of high-speed diesel in fiscal year 2025-26.

"This agreement marks an important milestone in our relationship with Praj and in the advancement of Bio-IBA in India," said Gevo Chief Executive Officer Paul Bloom.

"This Development & Commercialization Agreement establishes a strong foundation for bringing Bio-IBA to the Indian market," said Dr. Pramod Chaudhari, Founder Chairman of Praj Industries.

The press release also noted that Bio-IBA can serve as a platform molecule for producing Sustainable Aviation Fuel and other renewable chemicals. Praj Industries is listed on the BSE Limited and the National Stock Exchange of India.

You May Also Be Interested In

• Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
• Firefly Aerospace rises after Moon mission design review
• Interactive Brokers launches AI autonomous trading feature